ChinaPeptides: difference between revisions
Diff·revision 15 → 16·08:29, 5 Apr 2025
Difference between revision 15 and revision 16 of ChinaPeptides. 1 line changed; the page grew by 80 bytes.
| Revision 15 — 06:44, 17 Mar 2025 TallySheetTad (talk) expand §Regulatory position and legal status 7,287 bytes +274 | Revision 16 — 08:29, 5 Apr 2025 API_Aurora (talk) fix the anchor on an internal link 7,367 bytes +80 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Which name should the article title use?}} | |
| 21 | 22 | ||
| 22 | '''ChinaPeptides Co., Ltd. (QYAOBIO)''' (trading as '''QYB'''; qyaobiopeptides.com) is a peptide supplier trading as QYB from Shanghai, China, incorporated in 2008, whose catalogue centres on custom synthesis alongside a range of stock research peptides.{{r|registry,selfpub}} | 23 | '''ChinaPeptides Co., Ltd. (QYAOBIO)''' (trading as '''QYB'''; qyaobiopeptides.com) is a peptide supplier trading as QYB from Shanghai, China, incorporated in 2008, whose catalogue centres on custom synthesis alongside a range of stock research peptides.{{r|registry,selfpub}} |